LifeStance Health Group, Inc.·4

Mar 9, 8:13 PM ET

Eken Stephanie Carin 4

4 · LifeStance Health Group, Inc. · Filed Mar 9, 2026

Research Summary

AI-generated summary of this filing

Updated

LifeStance (LFST) CMO Stephanie Eken Receives 115,107 RSU Award

What Happened
Stephanie Carin Eken, Chief Medical Officer of LifeStance Health Group, was granted 115,107 restricted stock units (RSUs) on March 5, 2026. The Form 4 reports the acquisition price as $0.00 (transaction code A), i.e., an equity award rather than an open-market purchase or sale. The filing was made on March 9, 2026.

Key Details

  • Transaction date: 2026-03-05; Filing date: 2026-03-09 (Accession: 0001193125-26-099068).
  • Award: 115,107 RSUs; reported price: $0.00; total reported value: $0.
  • Shares owned after transaction: not specified in the provided data.
  • Footnote: Each RSU represents a contingent right to receive one share of the issuer's common stock upon vesting.
  • Transaction code: A (award/grant). No late filing flag was indicated in the provided information.

Context
RSUs are a form of equity compensation that typically convert to actual shares only after vesting and may be subject to service conditions and tax withholding. An RSU grant is routine compensation and does not represent an immediate market purchase or sale; it does not, by itself, indicate a near-term trading decision.

Insider Transaction Report

Form 4
Period: 2026-03-05
Eken Stephanie Carin
Chief Medical Officer
Transactions
  • Award

    Common Stock

    [F1]
    2026-03-05+115,107115,107 total
Footnotes (1)
  • [F1]Includes 115,107 restricted stock units ("RSUs") granted on March 5, 2026. Each RSU represents a contingent right to receive one share of the Issuer's common stock.
Signature
By: /s/ Ryan Pardo, Attorney-in-Fact|2026-03-09

Documents

1 file
  • 4
    ownership.xmlPrimary

    4